Inhibiting PI3K-AKt signaling pathway is involved in antitumor effects of ginsenoside Rg3 in lung cancer cell

Graphical abstract

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biomedicine & pharmacotherapy 2017-01, Vol.85, p.16-21
Hauptverfasser:	Xie, Qipeng, Wen, Huaikai, Zhang, Qiong, Zhou, Weihe, Lin, Xiaoming, Xie, Deyao, Liu, Yu
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Animals Antineoplastic Agents, Phytogenic - pharmacology Apoptosis Cell Line, Tumor Dose-Response Relationship, Drug Gene Expression Regulation - drug effects Ginsenoside Rg3 Ginsenosides - administration & dosage Ginsenosides - pharmacology Humans Internal Medicine Lung cancer Lung Neoplasms - drug therapy Medical Education Mice Mice, Nude Neoplasms, Experimental - drug therapy Phosphatidylinositol 3-Kinases - genetics Phosphatidylinositol 3-Kinases - metabolism Phytotherapy PI3K/Akt Proto-Oncogene Proteins c-akt - genetics Proto-Oncogene Proteins c-akt - metabolism Signal Transduction - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!